Perioperative anticoagulation and thrombolysis in congenital and acquired coagulopathies

Anesthesiology Clinics of North America

Volumn 17, Issue 4, 1999, Pages 923-958

  Kapural, L ^a   Sprung, J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APROTININ; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; STREPTOKINASE; UROKINASE; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; CANCER; CARDIOVASCULAR SURGERY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED DISEASE; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; THROMBOCYTOPENIA; THROMBOEMBOLISM; VON WILLEBRAND DISEASE;

EID: 0032712905     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8537(05)70140-1     Document Type: Article

References (210)

1. D.M. Aboulafia E.D. Aboulafia Aortic aneurysm-induced disseminated intravascular coagulation Ann Vasc Surg 10 1996 396
2. S.S. Ahn K. Kalunian M. Rosove Postoperative thrombotic complications in patients with the lupus anticoagulant: Increased risk after vascular procedures J Vasc Surg 7 1988 749
3. C.F. Allart D.C. Aronson T.H. Ruys Hereditary protein S deficiency in young adults with arterial occlusive disease Thromb Haemost 64 1990 206
4. B.M. Alving M.P. Strickler R.D. Knight Hereditary warfarin resistance Arch Intern Med 145 1985 499
5. American Society of Regional Anesthesia, Neuraxial anesthesia and coagulation. Consensus statement. Report from American Society of Regional Anesthesia Consensus Conference, Chicago, IL, May 2–3, 1998.
6. J. Amiral F. Bridey M. Dreyfus Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia Thromb Haemost 68 1992 95
7. P.R.J. Arnes S. Pyke L. Iannaconne Antiphospholipid antibodies, haemostatic variables and thrombosis—A survey of 144 patients Thromb Haemost 73 1990 768
8. B. Arnljots T. Soderstrom H. Svensson No correlation between activated protein C resistance and free flap failures in 100 consecutive patients Plast Reconstr Surg 101 1998 1850
9. R.A. Asherson J.K.H. Chan E.N. Harris Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal Ann Rheum Dis 44 1985 823
10. R.A. Asherson Antiphospholipid antibodies and syndromes Lahita R.G. Systemic lupus erythematosus ed 2 1992 Churchill Livingstone New York 587
11. T.L. Bauer G. Arepally B.A. Konkle Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 1997 1242
12. W.R. Bell N.F. Starksen S. Tong Trousseau's syndrome Am J Med 79 1985 423
13. W.R. Bell The pathophysiology of disseminated intravascular coagulation Semin Hematol 31 1994 19
14. D. Bergqvist L. Thimberg S.E. Bergentz Abdominal aortic aneurysm surgery in a hemophiliac Vasa 14 1985 394
15. R.M. Bertina P.C. Koeleman T. Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64
16. R.L. Bick Disseminated intravascular coagulation: Objective criteria for diagnosis and management Med Clin North Am 78 1994 511
17. B.P. Bidstrup D. Royston R.N. Sapsford Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol) J Thorac Cardiovasc Surg 97 1989 364
18. M. Blomback G. Johansson H. Johnsson Surgery in patients with von Willebrand's disease Br J Surg 76 1989 398
19. C.J. Bogdan M. Strauss O.D. Ratnoff Airway obstruction in hemophilia (Factor VIII deficiency): A 28-year institutional review Laryngoscope 104 1994 789
20. E.G. Bovill Laboratory diagnosis of disseminated intravascular coagulation Semin Hematol 31 1994 35
21. D.B. Brettler P.H. Levine Factor concentrates for treatment of hemophilia: Which one to choose? Blood 73 1989 2067
22. T. Brighton C.N. Chesterman Antiphospholipid antibodies and thrombosis Baillieres Clin Haematol 7 1994 541
23. A.W. Broekmans R.M. Bertina J. Reinalda Poot Hereditary protein S deficiency and venous thrombo-embolism Thromb Haemost 53 1985 273
24. A. Burick J.D. Wisotzkey M.P. Najarian The role of preoperative factor V Leiden screening in different geographic populations Am Surg 63 1997 547
25. C.B. Cameron N. Kobrinsky Perioperative management of patients with von Willebrand's disease Can J Anaesth 37 1990 341
26. M.L. Cecil P.J. Fenton W.T. Jackson The perioperative management of protein S deficiency in total hip arthroplasty Clin Orthop 303 1993 170
27. B.H. Chong Heparin-induced thrombocytopenia Aust NZJ Med 22 1992 145
28. R.T. Chung D.L. Jaffe L.S. Friedman Complications of chronic liver disease Crit Care Clin 11 1995 431
29. R.G. Ciocca J. Choi A.M. Graham Antiphospholipid antibodies lead to increased risk in cardiovascular surgery Am J Surg 170 1995 198
30. G.D. Clifton M.D. Smith Thrombolytic therapy in heparin-associated thrombocytopenia with thrombosis Clin Pharmacokinet 5 1988 579
31. A.J. Cohen C.M. Kessler Treatment of inherited coagulation disorders Am J Med 99 1995 675
32. J.R. Cohen W. Schroder J. Leal Mesenteric shunting during thoracoabdominal aortic clamping to prevent disseminated intravascular coagulation in dogs Ann Vasc Surg 2 1988 261
33. C.W. Cole L.M. Fournier J. Bormanis Heparin-associated thrombocytopenia and thrombosis: Optimal therapy with ancrod Can J Surg 33 1990 207
34. B.S. Coller J. Owen J. Jesty Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis Arteriosclerosis 7 1987 456
35. P.C. Comp R.R. Nixon M.R. Cooper Familial protein S deficiency is associated with recurrent thrombosis J Clin Invest 74 1984 2082
36. J.J. Corrigan C.M. Jordan Heparin therapy in septicemia with disseminated intravascular coagulation: Effect on mortality and correction of hemostatic defects N Engl J Med 283 1970 778
37. D.M. Cosgrove B. Heric B.W. Lytle Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study Ann Thorac Surg 54 1992 1031
38. B. Dahlback B. Hildebrand Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V Proc Natl Acad Sci USA 91 1994 1396
39. B. Dahlback J. Stenflo High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b binding protein Proc Natl Acad Sci USA 78 1981 2512
40. B. Dahlback M. Carlsson P.G. Svensson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C Proc Natl Acad Sci USA 90 1993 1004
41. F. D'Angelo S. Vigano-D'Angelo C.T. Esmon Acquired deficiencies of protein S J Clin Invest 81 1988 1445
42. S.R. Davies Systemic lupus erythematosus and the obstetrical patient–implications for the anaesthetist Can J Anaesth 38 1991 790
43. M. De Caterina G. Tarantino C. Farina Hemostasis unbalance in Pugh-scored liver chirrosis: Characteristic changes of plasma levels of protein C versus protein S Haemostasis 23 1993 229
44. R. De Paulis G. Bognolo F. Tomai Early coronary artery bypass graft thrombosis in a patient with protein S deficiency Eur J Cardiothorac Surg 10 1996 470
45. V. De Stefano G. Leone S. Mastrangelo Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S Thromb Haemost 71 1994 799
46. M. Deleze C.V. Oria D. Alarcon-Segovia Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans Syndrome) in systemic lupus erythematosus: Relationship to antiphospholipid antibodies J Rheumatol 15 1988 611
47. C. Demers J.S. Ginsberg J. Hirsh Thrombosis in antithrombin-III-deficient persons: Report of a large kindred and literature review Ann Intern Med 116 1992 754
48. R.h. Derksen P.G. de Groot L. Kater Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment Ann Rheum Dis 52 1993 689
49. V. DeStefano G. Leone S. Mastrangelo Clinical manifestation and management of inherited thrombophilia: Retrospective analysis and follow up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S Thromb Haemost 72 1994 352
50. C. Di Rocco A. Iannelli G. Leone Heparin-urokinase treatment in aseptic dural sinus thrombosis Arch Neurol 38 1981 431
51. R. Donadoni G. Baele J. Devulder Coagulation and fibrinolytic parameters in patient undergoing total hip replacement: Influence of the anesthesia technique Acta Anaesthesiol Scand 33 1989 588
52. M.C. Donaldson M. Belkin A.D. Whittemore Impact of activated protein C resistance on general vascular surgical patients J Vasc Surg 25 1997 1054
53. M.C. Donaldson D.S. Weinberg M. Belkin Screening for hypercoagulable states in vascular surgical practice: A preliminary study J Vasc Surg 11 1990 825
54. A.R. Ducart E.L. Collard J.C. Osselaer Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant J Cardiothorac Vasc Anesth 11 1997 878
55. J.D. Eason J.L. Mills W.C. Beckett Hypercoagulable states in arterial thromboembolism Surgery 174 1992 211
56. O. Egeberg Inherited antithrombin deficiency causing thrombophilia Thromb Diathesis Haemorh 13 1965 516
57. J. Eldrup-Jorgensen L. Brace P. Flaningan Lupus-like anticoagulants and lower extremity arterial occlusive disease Circulation 80 suppl 3 1989 54
58. M. Elias A. Eldor Thromboembolism in patient with the lupus type circulating anticoagulant Arch Intern Med 144 1984 510
59. L. Engesser A.W. Broekmans E. Briet Hereditary protein S deficiency: Clinical manifestations Ann Intern Med 106 1987 677
60. J. Eritsland G. Gjonnes P.M. Sandset Activated protein C resistance and graft occlusion after coronary artery bypass surgery Thromb Res 79 1995 223
61. C.T. Esmon The regulation of natural anticoagulant pathways Science 235 1987 1348
62. F. Espana A. Estelles J.H. Griffin Aprotinin (trasylol) is a competitive inhibitor of activated protein C Thromb Res 56 1989 751
63. S.Z. Fan M. Yeh W. Tsay Caesarean section in a patient with protein S deficiency Anaesthesia 50 1995 251
64. M. Fischereder P. Gohring H. Schneeberger Early loss of renal transplants in patients with thrombophilia Transplantation 65 1998 936
65. L.J. Fligelstone P.G. Cachia H. Ralis Lupus anticoagulant in patients with peripheral vascular disease: A prospective study Eur J Vasc Endovasc Surg 9 1995 227 283
66. P.W.X. Foley C.D. Irvine G.R. Standent Activated protein C resistance, factor V Leiden and peripheral vascular disease Cardiovasc Surg 5 1997 157
67. F. Fourrier C. Chopin J.J. Huart Double blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation Chest 104 1993 882
68. R.B. Francis W. Thomas Behavior of protein C inhibitor in intravascular coagulation and liver disease Thromb Haemost 52 1984 71
69. H. Fredin B. Nilsson B. Rosberg Pre- and postoperative levels of antithrombin III with special reference to thromboembolism after total hip replacement Thromb Haemost 49 1983 158
70. P.C. Gerszten W.C. Welch M.P. Spearman Isolated deep cerebral venous thrombosis treated by direct endovascular thrombolysis Surg Neurol 48 1997 261
71. A. Gibas J.L. Dienstag A.I. Schafer Cure of hemophilia A by orthotopic liver transplantation Gastroenterology 95 1988 192
72. D.L. Gillespie L.R. Carrington J.H. Griffin Resistance to activated protein C: A common inherited cause of venous thrombosis Ann Vasc Surg 10 1996 174
73. A. Girolami P. Simioni A.R. Lazzaro Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): A family study Thromb Haemost 61 1989 144
74. A.B. Glassmann E. Jones Thrombosis and coagulation abnormalities associated with cancer Ann Clin Lab Sci 24 1994 1
75. F.H. Gordon P.K. Mistry C.A. Sabin Outcome of orthotopic liver transplantation in patients with hemophilia Gut 42 1998 744
76. A. Gottlieb P. Levy A. Tabares The use of low molecular weight heparin in patients with heparin-induced thrombocytopenia undergoing carotid endarterectomy Anesthesiology 85 1996 678
77. M. Gouault-Heilmann C. Leroy-Matheron M. Levent Inherited protein S deficiency: Clinical manifestations and laboratory findings in 63 patients Thromb Res 76 1994 269
78. D. Green E.V. Potter Failure of AHF concentrate to control bleeding in von Willebrand's disease Am J Med 60 1976 357
79. H.B. Greig M. Notelowitz Natural oestrogens and antithrombin III levels Lancet 1 1975 412
80. J.H. Griffin D.F. Mosher T.S. Zimmerman Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation Blood 60 1982 261
81. H.P. Grocott F. Clements K. Landolfo Coronary artery bypass graft surgery in a patient with hereditary protein S deficiency J Cardiothorac Vasc Anesth 10 1996 915
82. A. Gruber A. Pal R. Kiss Generation of activated protein C during thrombolysis Lancet 342 1993 1275
83. G. Gula G. Frezza Successful surgery in a patient with hemophilia B: Report of a case with abdominal aneurysm Vasc Surg 4 1973 183
84. V. Hach-Wunderle K. Kainer G. Salzman Heparin-related thrombosis despite normal platelet counts in vascular surgery Am J Surg 173 1997 117
85. E.N. Harris J.K. Chan R.A. Asherson Thrombosis, recurrent fetal loss and thrombocytopenia: Predictive value of anticardiolipin antibody test Arch Intern Med 146 1986 2153
86. W.E. Hathaway Clinical aspects of antithrombin III deficiency Semin Hematol 28 1991 19
87. J. Hessing The interaction between complement component C4b-binding protein and vitamin K-dependent protein S forms a link between blood coagulation and the complement system Biochem J 277 1991 581
88. J. Hirsh F. Piovella M. Pini Congenital antithrombin III deficiency: Incidence and clinical features Am J Med 87 1989 34S
89. J. Hirsh The optimal duration of anticoagulation therapy in venous thromboembolism N Engl J Med 332 1995 1710
90. P.R. Howell M.J. Douglas Lupus anticoagulant, paramyotonia congenita and pregnancy Can J Anaesth 39 1992 992
91. C.F. Hoyle D.M. Swirsky L. Freeman Beneficial effect of heparin in management of patients with APL Br J Haematol 68 1988 283
92. J.B. Hunter R.J. Lonsdale P.W. Wenham Heparin induced thrombosis: An important complication of heparin prophylaxis for thromboembolic disease in surgery BMJ 307 1993 53
93. V.A. Hustead B.M. Wicklund Treatment of neonatal aortic thrombosis with urokinase Am J Pediatr Hematol Oncol 12 1990 336
94. S.J. Israels S.S. Seshia Childhood stroke associated with protein C and S deficiency J Pediatr 111 1987 562
95. M.R. Jackson C. Krishnamurti C.A. Aylesworth Diagnosis of heparin-induced thrombocytopenia in the vascular surgery patient Surgery 121 1997 419
96. M.R. Jackson S.B. Olsen E.R. Gomez Use of antithrombin III concentrates to correct antithrombin III deficiency during vascular surgery J Vasc Surg 22 1995 804
97. E.J. Johnson C.R.M. Prentice L.A. Parapia Premature arterial disease associated with familial antithrombin III deficiency Thromb Haemost 63 1990 13
98. Y. Kang Anesthesia for liver transplantation Anesthiol Clin North Am 7 1989 551
99. Y. Kang Coagulation and liver transplantation Transplant Proc 25 1993 2001
100. H.M. Kantarnijan M.J. Keating R.S. Walters Acute promyelocitic leukemia Am J Med 80 1986 789
101. R. Karl I. Garlick C. Zarins Surgical implications of antithrombin III deficiency Surgery 89 1981 429
102. R.H. Kauffmann J.J. Veltkamp N. van Tilburg Acquired AT III deficiency and thrombosis in nephrotic syndrome Am J Med 65 1978 607
103. J.P. Kelly L. Thomas P.V. Moulder Coronary bypass surgery in patients with circulating lupus anticoagulant Ann Thorac Surg 40 1985 261
104. J.S. Kennedy B.M. Gerety R. Siverman Simultaneous renal arterial and venous thrombosis associated with intra-arterial urokinase Am J Med 90 1991 124
105. S.C. Kettner C. Gonano F. Seebach Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation Anesth Analg 86 1998 691
106. M.A. Khamashta M.J. Cuardrado F. Mujic The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 1995 993
107. H.G. Klein W.R. Bell Disseminated intravascular coagulation during heparin therapy Ann Intern Med 80 1974 447
108. E.A.R. Knot E. de Jong J.W. Cate Antithrombin III: Biodistribution in healthy volunteers Thromb Haemost 58 1988 1008
109. M. Kobayashi M. Matsushita N. Nishikimi Treatment for abdominal aortic aneurysm in a patient with hemophilia A: A case report and review of the literature J Vasc Surg 25 1997 945
110. A. Koster H. Kuppe R. Hetzer Emergent cardiopulmonary bypass in five patients with heparin induced thrombocytopenia type II employing recombinant hirudin Anesthesiology 89 1998 777
111. T. Koster F.R. Rosendaal H. de Ronde Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study Lancet 342 1993 1503
112. L.A. Kunkel Acquired circulating anticoagulants in malignancy Semin Thromb Haemost 18 1992 416
113. M.J. Kupferminc A. Eldor N. Steinman Increased frequency of genetic thrombophilia in women with complications of pregnancy N Engl J Med 340 1999 9
114. S.A. Larsson Hemophilia in Sweden: Studies on demography of hemophilia and surgery in hemophilia and von Willebrand's disease Acta Med Scand 684 1984 1
115. K. Lechner Lupus anticoagulant and thrombosis Thromb Haemost 58 1987 525
116. R.W. Lee L.M. Taylor G.J. Landry Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies J Vasc Surg 24 1996 524
117. J.P. Lerut P.F. Laterre E. Lavenne-Pardogne Liver transplantation and hemophilia J Hepatol 22 1995 583
118. J.H. Levy Antithrombin deficiency in special clinical syndromes: Part II: Cardiovascular surgery Semin Hematol 32 suppl 2 1995 49
119. P.J. Levy A.H. Tabares J.W. Olin Disseminated intravascular coagulation associated with acute ischemic hepatitis after elective aortic aneurysm repair: Comparative analysis of 10 cases J Cardiothorac Vasc Anesth 11 1997 141
120. Lindblad B, Dahlback B: A new important factor for early femoro-crural graft occlusion-activated protein C resistance. In 1995 Joint Annual Meeting of the Society for Vascular Surgery (49th Annual Meeting) and The North American Chapter of the International Society for Cardiovascular Surgery (43rd Scientific Meeting)—St. Louis, Mosby, Posters Outline and Abstracts, 1995, p 19
121. S.S. Lo W.H. Hitzig P.G. Frick Clinical experience with anticoagulant therapy in the management of disseminated intravascular coagulation Acta Haematol 45 1971 1
122. M.D. Lokshin T. Quamar M.L. Druzin Hazards of lupus pregnancy J Rheumatol 14 1987 214
123. R. Madan M. Khoursheed R. Kukla The anaesthetist and the antiphospholipid syndrome Anaesthesia 52 1997 72
124. R.V. Majer M. Chisholm M.C. Hickton Replacement therapy for protein C deficiency using fresh frozen plasma Br J Haematol 72 1989 475
125. P.W. Majerus Bad blood by mutation Nature 369 1994 14
126. E.F. Mammen Coagulopathies of liver disease Clin Lab Med 14 1994 769
127. P.M. Mannucci S. Vigano Deficiencies of protein C, an inhibitor of blood coagulation Lancet 2 1982 463
128. E. Marciniak J.P. Gockerman Heparin-induced decrease in circulating antithrombin III Lancet 11 1977 581
129. R.A. Marlar R.H. Sills P.K. Groncy Protein C survival during replacement therapy in homozygous protein C deficiency Am J Hematol 41 1992 24
130. T. Matsuo K. Kairo Y. Chikahira Treatment of heparin-induced thrombocytopenia by use of argatroban, a syntetic thrombin inhibitor Br J Haematol 82 1992 627
131. E. McGinley G.D.O. Lowe M. Boulton-Jones Blood viscosity and haemostasis in the nephrotic syndrome Thromb Haemost 49 1983 155
132. R.F. McKee S. Hodson J. Dawes Plasma concentration of endogenous heparinoids in portal hypertension Gut 33 1992 1549
133. P.J. McKenzie Deep venous thrombosis and anaesthesia Br J Anaesth 66 1991 4
134. H.P. McNeil C.N. Chesterman S.A. Krilis Immunology and clinical importance of antiphospholipid antibodies Adv Immunol 49 1991 193
135. P.D. Meagher K.A. Rickard J.G. Richards Aortic and mitral valve replacement in a patient with severe hemophilia A Aust NZJ Med 11 1981 76
136. G. Menon J. Allt-Graham Anesthetic implications of the anticardiolipin antibody syndrome Br J Anaesth 70 1993 587
137. R.M. Merion R.E. Delius D.A. Campbell Orthotopic liver transplantation totally corrects factor IX deficiency in hemophilia B Surgery 104 1988 929
138. J. Modig T. Borg G. Karlstrom Thromboembolism after total hip replacement: Role of epidural and general anesthesia Anesth Analg 62 1983 174
139. E.C. Morrissey B.R. McDonald G.M. Rabetoy Resolution of proteinuria secondary to bilateral renal vein thrombosis after treatment with systemic thrombolytic therapy Am J Kidney Dis 29 1997 615
140. D.F. Mosher Disorders of blood coagulation Bennet J.C. Plum F. Cecil Textbook of Medicine ed 20 1996 WB Saunders Philadelphia 987
141. J.R. Mueh K.D. Herbst S.I. Rapaport Thrombosis in patient with the lupus anticoagulant Ann Intern Med 92 1980 156
142. C. Nahas J.W. Jones A.C. Beall Myocardial revascularization in a hemophiliac Cardiovasc Surg 4 1996 557
143. S. Nand H. Messmore Hemostasis in malignancy Am J Hematol 35 1990 45
144. S. Nand Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis Am J Hematol 43 1993 310
145. C. Negrier J. Goudemand Y. Sultan Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity Thromb Haemost 77 1997 1113
146. I.M. Nilsson E. Berntorp C. Freiburghaus Treatment of patients with factor VIII and IX inhibitors Thromb Haemost 70 1993 56
147. I.M. Nilsson S. Jonsson S.B. Sundquist A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia: Substitution therapy and surgery in patients with hemophilia B and antibodies Blood 58 1981 38
148. J. Nishioka K. Suzuki Inhibition of cofactor activity of protein S by a complex of protein S and C4b-binding protein: Evidence for inactive ternary complex formation between protein S, C4b-binding protein, and activated protein C J Biol Chem 265 1990 9072
149. U. Nowak-Gottl A. Dubbers D. Kececioglu Factor V Leiden, protein C and lipoprotein in catheter-related thrombosis in childhood: A prospective study J Pediatr 131 1997 608
150. G.N. Olinger C.V. Hussey J.A. Olive Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation J Thorac Cardiovasc Surg 87 1984 618
151. K. Ouriel R.M. Green J.A. DeWeese Activated protein C resistance: Prevalence and implications in peripheral vascular disease J Vasc Surg 23 1996 46
152. K. Ouriel F.J. Veith A.A. Sasahara Thrombolysis or peripheral arterial surgery: Phase I results J Vasc Surg 23 1996 64
153. S. Ozsosylou H.S. Strauss L.K. Diamond Effects of corticosteroids on coagulation of the blood Nature 196 1962 1214
154. I. Pabinger B. Schneider GTH Study Group Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency: A cooperative retrospective study Arterioscler Thromb Vasc Biol 16 1996 742
155. G. Paret A. Barzilai Z. Barzilay Purpura fulminans skin lesions in a newborn with complete protein C deficiency J Pediatr 132 1998 558
156. R.I. Parker Etiology and treatment of acquired coagulopathies in the critically ill adult and child Crit Care Clin 13 1997 591
157. E.J. Perrin M.J. Ray G.A. Hawson The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery Blood Coagul Fibrinolysis 6 1995 650
158. R.J. Porte F.A. Bontempo Y. Kang Systemic effects of TPA-associated fibrinolysis and its relationc to thrombin generation in orthotopic liver transplantation Transplantation 47 1989 978
159. C.M. Proby A. Chitolie D.H. Bevan Cutaneous necrosis associated with protein S deficiency J R Soc Med 83 1990 646
160. A.K. Rao S. Sheth R. Kaplan Inherited hypercoagulable states Vasc Med 2 1997 313
161. S.A. Ray M.R. Rowley D.H. Bevan Hypercoagulable abnormalities and postoperative failure of arterial reconstruction Eur J Endovasc Surg 13 1997 363
162. P.M. Ridker C.H. Hennekens J. Selhub Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of future venous thromboembolism Circulation 95 1997 1777
163. P.M. Ridker C.H. Hennekens K. Lindpaintner Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men N Engl J Med 332 1995 912
164. P.M. Ridker J.P. Miletich A.J. Stampfer Factor V Leiden and risk of recurrent idiopathic venous thromboembolism Circulation 92 1995 2800
165. M. Riewald H. Riess Treatment options for clinically recognized disseminated intravascular coagulation Semin Thromb Haemost 24 1998 53
166. M.R. Rinder R.E. Richard H.M. Rinder Acquired von Willebrand's disease: A concise review Am J Hematol 54 1997 139
167. B. Risberg S. Andreasson E. Eriksson Disseminated intravascular coagulation Acta Anaesthesiol Scand 95 1991 60
168. F. Rodeghieero G. Castaman E. Dini Epidemiological investigation of the prevalence of von Willebrand's disease Blood 69 1987 454
169. P.G. Rose G.F. Essig P.S. Vaccaro Protein S deficiency in pregnancy Am J Obstet Gynecol 155 1986 140
170. F.R. Rosendaal H. Heijboer E. Briet Mortality in hereditary antithrombin-III deficiency—1830 to 1989 Lancet 337 1991 260
171. F.R. Rosendaal T. Koster J.P. Vandenbroucke High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504
172. M.H. Rosove K. Tabsh N. Wasserstrum Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies Obstet Gynecol 75 1990 630
173. G.H. Sack J. Levin W.R. Bell Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features Medicine 56 1977 1
174. J.E. Saffitz D.J. Stahl T.M. Sundt Disseminated intravascular coagulation after administration of aprotinin in combination with deep hypothermic circulatory arrest Am J Cardiol 72 1993 1080
175. E.W. Salzman M.J. Weinstein R.M. Weintraub Treatment with desmopressin acetate to reduce blood loss after cardiac surgery N Engl J Med 314 1986 1402
176. L.R. Samaritano A.E. Gharavi M.D. Lockshin Antiphospholipid antibody syndrome: Immunologic and clinical aspects Semin Arthritis Rheum 20 1990 81
177. R.S. Schwartz K.A. Bauer R.D. Rosenberg Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin: The antithrombin III study group Am J Med 87 3B 1989 3B 53S
178. A.E. Seyfer A.V. Seaber F.A. Dombrose Coagulation changes in elective surgery and trauma Ann Surg 193 1981 210
179. S.S. Shapiro The lupus anticoagulant/antiphospholipid syndrome Annu Rev Med 47 1996 533
180. D. Sheridan C. Carter J.G. Kelton A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27
181. M. Shimada T. Matsumata T. Kamakura Changes in regulating blood coagulation in hepatic resection with special references to soluble thrombomodulin and protein C J Am Coll Surg 178 1994 65
182. R.I. Shopnick D.B. Brettler Hemostasis: A practical review of conservative and operative care Clin Orthop 328 1996 34
183. C.K. Shortell K. Ouriel R.M. Green Vascular disease in the antiphospholipid syndrome: A comparison with the patient population with atherosclerosis J Vasc Surg 15 1992 158
184. G.D. Shorten M.E. Comunale Heparin-induced thrombocytopenia J Cardiothorac Vasc Anesth 10 1996 521
185. H.P. Shwartz M. Fischer P. Hopmeier Plasma protein S deficiency in familial thrombotic disease Blood 64 1984 1297
186. F.A. Siddiqi J. Tepler G.A. Fantini Acquired protein S and antithrombin III deficiency caused by nephrotic syndrome: An unusual cause of graft thrombosis J Vasc Surg 25 1997 576
187. P. Sie B. Boneu R. Bierme Arterial thrombosis and protein S deficiency Thromb Haemost 62 1989 1040
188. X. Sun B. Evatt J.H. Griffin Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia Blood 83 1994 3120
189. T.M. Sundt N.T. Kouchoukos J.E. Saffitz Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest Ann Thorac Surg 55 1993 1418
190. P.J. Svensson G. Benoni H. Fredin Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty Thromb Haemost 78 1997 993
191. P.J. Svensson B. Dahlback Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517
192. J.D. Sweeney A.J. Blair M.P. Dupuis Aprotinin, cardiac surgery and factor V Leiden Transfusion 37 1997 1173
193. S. Takeda H. Katoh A. Takaki Increase fibrin/fibrinogen degradation products without increase of plasmin-2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma Thromb Res 557 1990 289
194. L.M. Taylor R.W. Chitwood R.L. Dalman Antiphospholipid antibodies in vascular surgery patients: A cross-sectional study Ann Surg 220 1994 544
195. L. Tengborn D. Berquist Surgery in patients with congenital antithrombin III deficiency Acta Chir Scand 154 1988 179
196. J.F. Thompson Muellee P.R.F. Bell Intraoperative heparinization, blood loss and myocardial infarction during aortic aneurysm surgery: A joint vascular research group study Eur J Vasc Endovasc Surg 12 1996 86
197. D.A. Triplett Antiphospholipid-protein antibodies: Laboratory detection and clinical relevance Thromb Res 78 1995 1
198. T. Tsuzuki K. Toyama K. Nakayasu Disseminated intravascular coagulation after hepatic resection Surgery 107 1990 172
199. N. Ueda Effects of corticosteroids on coagulation factors in children with nephrotic syndrome Pediatr Nephrol 1 1987 286
200. J.C. Woude Vander J.D. Milam W.E. Walker Cardiovascular surgery in patients with congenital plasma coagulopathies Ann Thorac Surg 46 1988 283
201. H. Vielhaber B. Kohlhase H.G. Koch Flush heparin during cardiac catheterization prevents long-term coagulation activation in children without APC-resistance–Preliminary results Thromb Res 81 1996 651
202. S. Vigano-D'Angelo A. D'Angelo C.E. Kaufman Protein S deficiency occurs in nephrotic syndrome Kidney Int 31 1987 1396
203. G.P. Vinsentin S.E. Ford J.P. Scott Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells J Clin Invest 93 1994 81
204. P.P. Vomberg C. Breederveld P. Fleury Cerebral thromboembolism due to antithrombin III deficiency in two children Neuropediatrics 18 1987 42
205. T. Vukovich K. Auberger J. Weil Replacement therapy for a homozygous protein C deficiency-state using a concentrate of human protein C and S Br J Haematol 70 1988 435
206. T. Warkentin M.N. Levine J. Hirsh Heparin-induced thrombocytopenia in patients treated with low molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330
207. T.E. Warkentin J.G. Kelton Heparin and platelets Hematol Oncol Clin North Am 4 1990 243
208. M. Weinstein J.A. Ware J. Troll Changes in von Willebrand factor during cardiac surgery: Effects of desmopressin acetate Blood 71 1988 1648
209. J.L. Yakway Acquired von Willebrand's disease in malignancy Semin Thromb Haemost 18 1992 438
210. B. Zoller B. Dahlback Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis Lancet 343 1994 1536